911787-48-9Relevant academic research and scientific papers
COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page/Page column 81, (2010/06/19)
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
-
Page/Page column 166, (2010/11/24)
The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.
